dihexa hgf c-met potentiator Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion | Cell Communication and Signaling HGF/c-MET pathway in cancer: from
HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene HGF and MET: From Brain Development to Neurological Disorders PMC Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Frontiers HGF c Met: A Key Promoter in Liver Regeneration
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




